Cargando…
Deficiency of NEIL3 Enhances the Chemotherapy Resistance of Prostate Cancer
Acquired treatment resistance is an important cause of death in prostate cancer, and this study aimed to explore the mechanisms of chemotherapy resistance in prostate cancer. We employed castration-resistant prostate cancer (CRPC), neuroendocrine prostate cancer (NEPC), and chemotherapy-resistant pr...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071437/ https://www.ncbi.nlm.nih.gov/pubmed/33921035 http://dx.doi.org/10.3390/ijms22084098 |